These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy. Esan O; Wierzbicki AS Drug Des Devel Ther; 2020; 14():2623-2636. PubMed ID: 32753844 [TBL] [Abstract][Full Text] [Related]
23. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report. Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710 [TBL] [Abstract][Full Text] [Related]
26. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Chyzhyk V; Brown AS Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756 [TBL] [Abstract][Full Text] [Related]
27. Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy. Suga S; Tamasawa N; Kinpara I; Murakami H; Kasai N; Onuma T; Ikeda Y; Takagi A; Suda T J Intern Med; 1998 Apr; 243(4):317-21. PubMed ID: 9627147 [TBL] [Abstract][Full Text] [Related]
28. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome. Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655 [TBL] [Abstract][Full Text] [Related]
29. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. Santos RD; Lorenzatti A; Corral P; Nogueira JP; Cafferata AM; Aimone D; Lourenço CM; Izar MC; Lima JG; Lottenberg AM; Alonso R; Garay K; Morales AR; Vargas-Uricoechea H; Peña CAC; Roman-González A J Clin Lipidol; 2021; 15(5):620-624. PubMed ID: 34920815 [TBL] [Abstract][Full Text] [Related]
30. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome. Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815 [TBL] [Abstract][Full Text] [Related]
31. Hypertriglyceridaemia in adolescents may have serious complications. Korf M; Zöllner EW; Solomon GEA; Zemlin AE; Marais AD S Afr Med J; 2022 Apr; 112(5):307-312. PubMed ID: 35587241 [TBL] [Abstract][Full Text] [Related]
33. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome. Paquette M; Hegele RA; Paré G; Baass A J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893 [TBL] [Abstract][Full Text] [Related]
34. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347 [TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Update on the Chylomicronemia Syndrome. Goldberg RB; Chait A Front Endocrinol (Lausanne); 2020; 11():593931. PubMed ID: 33193106 [TBL] [Abstract][Full Text] [Related]
36. Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene. Overgaard M; Brasen CL; Svaneby D; Feddersen S; Nybo M Ann Clin Biochem; 2013 Jul; 50(Pt 4):374-9. PubMed ID: 23761384 [TBL] [Abstract][Full Text] [Related]
37. The molecular basis of familial chylomicronemia. Ameis D; Schotz C; Greten H Z Gastroenterol Verh; 1991 Mar; 26():102-3. PubMed ID: 1714114 [No Abstract] [Full Text] [Related]
38. Triglyceride metabolism and classification of hypertriglyceridemias. Ibarretxe D; Masana L Clin Investig Arterioscler; 2021 May; 33 Suppl 2():1-6. PubMed ID: 34006348 [TBL] [Abstract][Full Text] [Related]
39. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054 [TBL] [Abstract][Full Text] [Related]
40. Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report. Tünnemann-Tarr A; Scharnagl H; Katzmann JL; Stürzebecher P; Laufs U Medicine (Baltimore); 2021 Oct; 100(42):e27573. PubMed ID: 34678899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]